[
  {
    "ts": null,
    "headline": "Henry Schein: The Case For An Upgrade From Hold To Buy",
    "summary": "Henry Schein shifts to higher-margin businesses in dental & medical markets. Upgraded to BUY with 24-30% upside by 2027.",
    "url": "https://finnhub.io/api/news?id=fda0725919576a9daaf739961e33e1c4b8a872a0e769f537fcf45d3396b3b36e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755179423,
      "headline": "Henry Schein: The Case For An Upgrade From Hold To Buy",
      "id": 136350202,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072549498/image_1072549498.jpg?io=getty-c-w1536",
      "related": "HSIC",
      "source": "SeekingAlpha",
      "summary": "Henry Schein shifts to higher-margin businesses in dental & medical markets. Upgraded to BUY with 24-30% upside by 2027.",
      "url": "https://finnhub.io/api/news?id=fda0725919576a9daaf739961e33e1c4b8a872a0e769f537fcf45d3396b3b36e"
    }
  }
]